Exscientia raises $60 million in Series C financing round led by Novo Holdings
Portfolio company Exscientia Limited has raised $60 million through a Series C financing round.
Read moreMolendotech raises £425,000 to accelerate development of novel rapid tests for harmful bacteria
Molendotech has raised £425,000 to accelerate development of its innovative rapid pathogen detection technology through an equity funding round.
Read moreAlusid can now make 1,000m2 a day on industry-standard manufacturing equipment
A 1,000m2 a day of tiles made from 95 per cent more recycled material – on industry standard manufacturing equipment.
View hereStep change for battery charger efficiency
Pulsiv Solar improves power factor to more than 90 per cent – technology can also used in everyday power converters and solar micro-inverters.
View herePulsiv Solar shows strong progress in developing battery charger technology and gains new patent
Pulsiv Solar Limited has been granted a patent in Japan, further strengthening its intellectual property position
Read moreAlusid launches luxury Block range through Kickstarter campaign
Alusid has launched a new luxury brand called Block via an exclusive Kickstarter campaign in collaboration with design consultancy Collective HQ.
Read moreExscientia announces joint initiave to identify COVID-19 drugs with Diamond Light Source and Scripps Research
Exscientia announced a joint initiative to progress compounds that could rapidly become viable drugs for the rapid treatment of COVID-19.
Read moreFrontier IP ‘in strong position’ and working closely with portfolio companies to mitigate new risks
Frontier IP Group PLC’s (LON:FIPP) Neil Crabb speaks to Proactive London’s Andrew Scott to discuss how the Intellectual property specialist’s portfolio companies are adapting to […]
View hereThe Vaccine Group starts work on COVID-19 animal vaccine
Move follows significant progress across several projects
View hereStrong interims and handling the COVID-19 risk
Chief executive Neil Crabb on adapting to the virus threat and half-year results
View here